New injection could ease pain for abortion patients
NCT ID NCT07487246
First seen Apr 02, 2026 · Last updated May 01, 2026 · Updated 6 times
Summary
This study tests whether a vaginal injection of ketorolac (an anti-inflammatory) plus lidocaine (a numbing agent) can reduce pain when placing osmotic dilators for second-trimester abortion. About 76 adults will receive either the combined injection or standard care. The goal is to improve pain control and reduce the need for opioid painkillers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.